ZUMUTOR BIOLOGICS
Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment.
ZUMUTOR BIOLOGICS
Industry:
Biotechnology Oncology Therapeutics
Founded:
2015-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.zumutor.com
Total Employee:
11+
Status:
Active
Total Funding:
47.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Euro Apple Mobile Web Clips Icon Google Analytics Google Maps WordPress
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Siana Capital Management
Siana Capital Management investment in Series A - Zumutor Biologics
Accel
Accel investment in Series A - Zumutor Biologics
Bharat Innovation Fund
Bharat Innovation Fund investment in Series A - Zumutor Biologics
Bharat Innovation Fund
Bharat Innovation Fund investment in Series A - Zumutor Biologics
Accel
Accel investment in Series A - Zumutor Biologics
Five Rivers Solutions
Five Rivers Solutions investment in Corporate Round - Zumutor Biologics
Chiratae Ventures
Chiratae Ventures investment in Seed Round - Zumutor Biologics
Aarin Capital
Aarin Capital investment in Seed Round - Zumutor Biologics
Accel
Accel investment in Seed Round - Zumutor Biologics
Karnataka Information Technology Venture Capital Fund
Karnataka Information Technology Venture Capital Fund investment in Seed Round - Zumutor Biologics
Official Site Inspections
http://www.zumutor.com Semrush global rank: 5.05 M Semrush visits lastest month: 1.61 K
- Host name: 104.21.86.119
- IP address: 104.21.86.119
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zumutor Biologics"
About - Zumutor Biologics
About Zumutor Founded in 2015, we are headquartered in Woburn, MA, USA with a ISO 9001:2008 laboratory in Bangalore, India. We have raised a total of 12M$ in capital from Accel โฆSee details»
Zumutor Biologics - Crunchbase Company Profile & Funding
Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies โฆSee details»
Zumutor Biologics - LinkedIn
Zumutor Biologics | 6,520 followers on LinkedIn. A leading Immuno Oncology company in the space of NK cell therapeutics | At Zumutor, we are on a mission to develop novel novel โฆSee details»
Zumutor - Company Profile - Tracxn
Aug 17, 2021 Zumutor ranks 92nd among 591 active competitors. 206 of its competitors are funded while 147 have exited. Overall, Zumutor and its competitors have raised over $22.5B in โฆSee details»
Zumutor Biologics | LinkedIn
Zumutor Biologics | 6,537 followers on LinkedIn. A leading Immuno Oncology company in the space of NK cell therapeutics | At Zumutor, we are on a mission to develop novel novel โฆSee details»
Zumutor Biologics - Overview, News & Similar companies
Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors Catalent, the leading global provider of advanced delivery technologies, development, โฆSee details»
Zumutor Biologics Company Profile - Office Locations ... - Craft
Zumutor Biologics has 5 employees across 2 locations and $15.5 m in total funding,. See insights on Zumutor Biologics including office locations, competitors, revenue, financials, executives, โฆSee details»
Zumutor Biologics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... obfuscated. obfuscated โ Nov 28, 2019: Series A - Zumutor Biologics . โฆSee details»
zumutor - Products, Competitors, Financials, Employees, โฆ
Zumutor Biologics founder and CEO Kavitha Iyer Rodrigues said: โWe believe that newer therapies like ZM008 will usher in options for patients and translate to better clinical outcomes. โฆSee details»
Zumutor - VentureRadar
Developing next generation biologics for novel targets using proprietary antibody engineering platforms. ... Find out more about Zumutor, Biotechnology, Biotech and Biologics.See details»
Zumutor Biologics Inc announces FDA clearance of IND โฆ
Aug 11, 2023 Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces โฆSee details»
Technology - Zumutor Biologics
Apr 8, 2021 Zumutorโs ADCC improvement platform is ready to deploy. Zumutor has developed multiple expression platforms which lead to improvement of antibody dependent cellular โฆSee details»
Zumutor Biologics to test its solid tumour therapy - Happiest Health
Aug 14, 2023 With quotes from Dr Maloy Ghosh (CSO, Zumutor Biologics), Dr Kavitha Iyer Rodrigues (CEO & founder, Zumutor biologics) Representational image | Shutterstock Boston โฆSee details»
Zumutor โ Licensing Opportunity for Next Generation Tumor โฆ
Zumutor Biologics is a biotechnology company based in Boston, USA, and Bangalore, India, focused on advancing innovative cancer immunotherapies. The company is interested in โฆSee details»
Zumutor inches closer to crucial milestone for biotech startups โฆ
Jul 14, 2022 ๏ปฟ Zumutor Biologics ๏ปฟ is among a new breed of biotech startups from India focused on immuno-oncology โ treatment that boosts the immune system to fight cancer. โฆSee details»
Zumutor and Enzene Join Forces for Breakthrough Antibody
Oct 22, 2023 Zumutor Biologics Inc. and Enzene Biosciences Ltd. have announced a collaboration to leverage Zumutor's INABLRä Antibody discovery platform. Zumutor's โฆSee details»
First-in-Human Phase 1 Clinical Trial (NCT06451497) in Solid โฆ
Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in-Class Anti LLT1 Antibody First-in-Human Phase 1 Clinical Trial (NCT06451497) in Solid Tumor Patients, โฆSee details»
Zumutor Biologics Announces Dosing of First Patient with ZM008, โฆ
Jun 13, 2024 First-in-Human Phase 1 Clinical Trial (NCT06451497) in Solid Tumor Patients, Begins Across Multiple Sites in the US. BOSTON, MA, USA I June 12, 2024 I Zumutor โฆSee details»
Syngene International Announces Partnership with Zumutor โฆ
Zumutor Biologics for Biotherapeutic Antibody Discovery Services 30th May, 2018, Bengaluru, India and Boston, USA Syngene International, a leading global Contract Research Services โฆSee details»